Show simple item record

Patient-centred outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rupacarib maintenance treatment in patients with recurrent ovarian carcinoma

dc.contributor.authorBedel, D
dc.contributor.authorLorusso, D
dc.contributor.authorAghajanian, C
dc.contributor.authorOaknin, A
dc.contributor.authorDean, A
dc.contributor.authorColombo, N
dc.contributor.authorWeberpals, JI
dc.contributor.authorClamp, Andrew R
dc.contributor.authorScambia, G
dc.contributor.authorLeary, A
dc.contributor.authorHolloway, RW
dc.contributor.authorAmenedo, Gancedo M
dc.contributor.authorFong, PC
dc.contributor.authorO'Malley, DM
dc.contributor.authorMeunier, J
dc.contributor.authorGoble, S
dc.contributor.authorCameron, T
dc.contributor.authorMork, AC
dc.contributor.authorLedermann, JA
dc.contributor.authorColeman RL
dc.date.accessioned2019-09-11T09:09:10Z
dc.date.available2019-09-11T09:09:10Z
dc.date.issued2019en
dc.identifier.citationBedel DJ, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, et al. Pcn295 Patient-centred outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rupacarib maintenance treatment in patients with recurrent ovarian carcinoma. Value Health. 2019;22:S112.en
dc.identifier.doi10.1016/j.jval.2019.04.414en
dc.identifier.urihttp://hdl.handle.net/10541/621969
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jval.2019.04.414en
dc.titlePatient-centred outcomes in ARIEL3, a phase 3, randomized, placebo-controlled study of rupacarib maintenance treatment in patients with recurrent ovarian carcinomaen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentClovis Oncology Switzerland GmBH, Zurich, Switzerlanden
dc.identifier.journalValue in Healthen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record